Cyclopharm Limited (ASX:CYC)

Cyclopharm Revenue

Cyclopharm had revenue of 17.52M AUD in the half year ending June 30, 2026, with 42.74% growth. This brings the company's total for the last twelve months to 34.42M, up 12.05% year-over-year. In the year 2025, Cyclopharm had annual revenue of 32.33M with 17.24% growth. That makes Cyclopharm the 32,690th largest company in the world by revenue and 567th in Australia.

• Revenue (ttm): 34.42M
• Revenue Growth: +12.05%
• P/S Ratio: 1.55
• Revenue / Employee: 330.99K
• Employees: 104
• Market Cap: 57.84M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Europe 19.56M 60.5%
• Asia Pacific 7.10M 22.0%
• United States Of America (2) 2.70M 8.3%
• Canada 2.36M 7.3%
• Other 618.06K 1.9%

Fiscal year ended Dec 31, 2025 See the full Cyclopharm breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	32.33M	4.75M	17.24%
Dec 31, 2024	27.57M	1.23M	4.68%
Dec 31, 2023	26.34M	1.48M	5.97%
Dec 31, 2022	24.85M	4.86M	24.30%
Dec 31, 2021	20.00M	2.31M	13.09%

Data Source: S&P Global Market Intelligence Last updated: Aug 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 1, 2026

Data Sources Report a data error